The Antenatal Corticosteroids Trial (ACT)'s explanations for neonatal mortality - A secondary analysis

Reproductive Health

Volumn 13, Issue 1, 2016, Pages

  Althabe, Fernando ^a   Thorsten, Vanessa ^b   Klein, Karen ^a   McClure, Elizabeth M ^b   Hibberd, Patricia L ^c   Goldenberg, Robert L ^d   Carlo, Waldemar A ^e   Garces, Ana ^f   Patel, Archana ^g   Pasha, Omrana ^h   Chomba, Elwyn ⁱ   Krebs, Nancy F ^j   Goudar, Shivaprasad ^k   Derman, Richard J ^l   Esamai, Fabian ^m   Liechty, Edward A ⁿ   Hansen, Nellie I ^b   Meleth, Sreelatha ^b   Wallace, Dennis D ^b   Koso Thomas, Marion ^o   Jobe, Alan H ^p   Buekens, Pierre M ^q   Belizán, José M ^a   more..

^a INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^b RTI INTERNATIONAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Howard Hughes Medical Institute   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Fundacion para la Alimentacion y Nutricion de Centro America y Panama   (Guatemala)

^g GOVERNMENT MEDICAL COLLEGE   (India)

^h AGA KHAN UNIVERSITY   (Pakistan)

ⁱ UNIVERSITY TEACHING HOSPITAL   (Zambia)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^k JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

^l Christiana Health Care ^*  (United States)

^m MOI UNIVERSITY   (Kenya)

ⁿ INDIANA UNIVERSITY   (United States)

^o EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^p CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^q TULANE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID;

ARTICLE; BACTERIAL INFECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN MORTALITY; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; SURVIVAL RATE; CLINICAL TRIAL; DEVELOPING COUNTRY; ETIOLOGY; INFANT; INFANT MORTALITY; MULTICENTER STUDY; PERINATAL DEATH; PREGNANCY; PREMATURE BIRTH; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STANDARDS;

DEVELOPING COUNTRIES; FEASIBILITY STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; PERINATAL DEATH; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; RISK FACTORS;

EID: 84970024938     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/s12978-016-0175-3     Document Type: Article

References (20)

1. March of Dimes, PMNCH, Save the Children, WHO. In: Howson CP, Kinney MV, Lawn JE, editors. Born Too Soon: The Global Action Report on Preterm Birth. Geneva: World Health Organization; 2012.
2. Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn J. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol. 2010;39 suppl 1:122-33.
3. National Institutes of Health. The effect of corticosteroids for fetal maturation on perinatal outcomes. Consensus Development Conference Statement, Feb 28-March 2, 1994. http://consensus.nih.gov/1994/1994AntenatalSteroidPerinatal095html.htm. Accessed 1 June 2014.
4. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:1-141.
5. Katz J, Lee A, Kozuki N, the CHERG Small-for-Gestational-Age-Preterm Birth Working Group. Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis. Lancet. 2013;382:417-25.
6. Bhutta Z, Das J, Bahl R, The Lancet Newborn Interventions Review Group and The Lancet Every Newborn Study Group. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet. 2014;384:347-70.
7. Lawn J, Blencowe H, Oza S, The Lancet Every Newborn Study Group. Every Newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189-205.
8. Vargas-Origel A, Leon Ramirez D, Zamora-Orozco J. Corticoesterides antenatales: empleo y actitud del personal medico ginecoobstetra. Ginecol Obstet Mex. 2000;68:291-5.
9. The World Health Organization Expert Committee. The selection and use of essential medicines: report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essentials Medicines for Children). Geneva: World Health Organization: 2013.
10. UN Commission on Life-Saving Commodities for Women and Children. Commissioners' report September.2012. http://www.unicef.org/media/files/UN-Commission-Report-September-2012-Final.pdf. Accessed 15 Oct 2015.
11. Althabe F, Belizán JM, Mazzoni A, et al. Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol. Reprod Health. 2012;9:22.
12. Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629-39.
13. Bose CL, Bauserman M, Goldenberg RL, Goudar SS, McClure EM, Pasha O, Carlo WA, Garces A, Moore JL, Miodovnik M, Koso-Thomas M. The Global Network Maternal Newborn Health Registry: a multi-national, community-based registry of pregnancy outcomes. Reprod Health. 2015;12 Suppl 2:S1.
14. Goudar SS, Carlo WA, McClure EM, et al. The Maternal and Newborn Health Registry study of the Global Network for Women's and Children's Health Research. Int J Gynecol Obstet. 2012;118:190-3.
15. Silva L, Costa T, Reis A, Iamada N, Azevedo A, Albuquerque C. Assessment of quality of obstetric hospital care: use of corticoid in preterm labor. Cad Saude Publica. 1999;15:817-29.
16. Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E, Goudar SS, Patel A, Esamai F, Garces A, Kodkany B, Belizan J, McClure EM, Derman RJ, Hibberd P, Liechty EA, Hambidge KM, Carlo WA, Buekens P, Moore J, Wright LL, Goldenberg RL; EmONC Trial Group. Assessment of obstetric and neonatal health services in developing country health facilities. Am J Perinatol. 2013;30(9):787-94.
17. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of IkappaB synthesis. Science. 1995;270(5234):286.
18. Young Infants Clinical Signs Study Group. Clinical signs that predict severe illness in children under age 2 months: a multicentre study. Lancet. 2008;371(9607):135-42.
19. Seale AC, Blencowe H, Manu AA, Nair H, Bahl R, Qazi SA, et al. Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(8):731-41.
20. McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Aust N Z J Obstet Gynaecol. 2003;43(2):101-6.